NEW YORK–(BUSINESS WIRE)–Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and providers of cannabis products in the U.S., announced its Seed & Strain brand pre-rolls will be available today at all four of its dispensaries in New York,…
BURLINGTON, Ontario–(BUSINESS WIRE)–Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, is providing a bi-weekly default status update in accordance with National Policy 12-203 – Management Cease Trade Orders (“NP 12-203”). The Company announced via press release dated June 16, 2022 (the “Default Announcement”) that…
MOUNT VERNON, NY–(BUSINESS WIRE)–Applied UV, Inc. (NasdaqCM: AUVI) (“Applied UV” or the “Company”), a pathogen elimination technology company that applies the power of narrow-range ultraviolet light (“UVC”) for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced that the Company will be hosting an investor conference call…
SEATTLE–(BUSINESS WIRE)–Leafly Holdings, Inc. (“Leafly” or “the Company”) (NASDAQ: LFLY), a leading online cannabis discovery marketplace and resource for cannabis consumers, today announced financial results for its second quarter ended June 30, 2022. “Revenue in the quarter was $12.1 million, up 13.8% over Q2 last year, and up 5.5% over Q1 as we continue to…
CHICAGO–(BUSINESS WIRE)–JohnsByrne Company, a leading supplier of premium packaging and high-impact direct mail, is pleased to announce the acquisition and installation of our newest CO2-neutral, Heidelberg Speedmaster XL eight-color press. The press is the latest capital investment in JohnsByrne’s commitment as an industry-leading provider of sustainable packaging. “We are committed to investing in people and…
SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Under the header Six Months and Second Quarter Ended June 30, 2022 Financial Results, fourth bullet should read: compared to $550,064 for the second quarter ended June 30, 2021 (instead of compared to $445,479 for the second quarter ended June 30, 2021) The updated release reads: ZONED PROPERTIES REPORTS SECOND QUARTER 2022 FINANCIAL…
COSTA MESA, Calif.–(BUSINESS WIRE)–Gold Flora — a leading vertically-integrated California cannabis company — today announced the launch of its revamped Luxe Collection disposable vape pen, the most comprehensive update for the collection since the line was introduced in 2018. A full inch smaller than its predecessor but with twice the oil and an exclusive new…
MIAMI–(BUSINESS WIRE)–Cookies today announced its much-anticipated debut in Florida’s medical cannabis market with the opening of Cookies Miami, the brand’s 52nd dispensary, in a location convenient to the airport and downtown. The new 3,100 square-foot location will host a unique menu featuring Cookies’ highly sought after genetics and custom Cookies SF local reserve merchandise. “The…
SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Zoned Properties®, Inc. (“Zoned Properties” or the “Company”) (OTCQB: ZDPY), a leading real estate development firm for emerging and highly regulated industries, including legalized cannabis, today announced its financial results for the second quarter ended June 30, 2022. “The Zoned Properties team has positioned the Company for national scale and growth, and we…
AUSTIN, Texas & ROTTERDAM, Netherlands–(BUSINESS WIRE)–Fluence Bioengineering, Inc. (Fluence), a leading global provider of energy-efficient LED lighting solutions for commercial cannabis and food production, in collaboration with REMY, a horticultural lighting provider to Israel’s growing agriculture industry, is supporting the record introduction of lighting technology solutions to Israel’s medical cannabis facilities. Israel—considered a world leader…
RADNOR, Pa.–(BUSINESS WIRE)–Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today reported business highlights and financial results for the second quarter ended June 30, 2022. “We had an exciting second quarter as we continued to prepare for the commercial launch of ZTALMY and progressed…
FLORENCE, Italy & NEW YORK–(BUSINESS WIRE)–The Menarini Group (“Menarini”), a privately held Italian pharmaceutical and diagnostics company, and Stemline Therapeutics (“Stemline”), a wholly-owned subsidiary of the Menarini Group, today announced that the U.S. Food and Drug Administration (FDA) has accepted the Company’s New Drug Application (NDA) for elacestrant, an investigational selective estrogen receptor degrader (SERD),…